Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, the highest Dividend Payout Ratio of Dimed Distribuidora de Medicamentos was 0.79. The lowest was 0.07. And the median was 0.30.
During the past 12 months, Dimed Distribuidora de Medicamentos's average Dividends Per Share Growth Rate was -18.20% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 15.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 48.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 10.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dimed Distribuidora de Medicamentos was 51.50% per year. The lowest was -43.40% per year. And the median was 15.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos Dividend Yield % Chart
BSP:PNVL3 vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dimed Distribuidora de Medicamentos Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Dimed Distribuidora de Medicamentos's Dividend Yield % falls into.
Dimed Distribuidora de Medicamentos Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Dimed Distribuidora de Medicamentos Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
BRL 0.120563
2026-06-29
2026-06-26
0000-00-00
Cash Dividend
quarterly
BRL:BRL 1.000000
BRL 0.087228
2026-03-27
2026-03-26
0000-00-00
Cash Dividend
quarterly
BRL:BRL 1.000000
BRL 0.147869
2026-01-16
2026-01-15
0000-00-00
Cash Dividend
quarterly
BRL:BRL 1.000000
BRL 0.020098
2025-10-06
2025-10-03
2026-05-29
Cash Dividend
quarterly
BRL:BRL 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Dividend Yield % of 3.33% as of Jul. 14, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Dimed Distribuidora de Medicamentos and its competitors. This is 164% above median its historical median of 1.26. Over the past decade, Dimed Distribuidora de Medicamentos' Dividend Yield % has ranged from 0.10 to 5.61. According to the industry distribution chart, Dimed Distribuidora de Medicamentos ranks #136 out of 516 companies in the Drug Manufacturers industry, placing it in the top 26.4%.
Is Dimed Distribuidora de Medicamentos' Dividend Yield % too high?
Dimed Distribuidora de Medicamentos' current Dividend Yield % of 3.33% is 164% above median its 10-year median of 1.26. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 5.61. The Drug Manufacturers industry median Dividend Yield % is 1.93. Dimed Distribuidora de Medicamentos' value of 3.33% is 72.5% above this industry median. Based on the distribution chart, Dimed Distribuidora de Medicamentos ranks #136 out of 516 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dimed Distribuidora de Medicamentos ranks #136 out of 516 companies for Dividend Yield %. This puts Dimed Distribuidora de Medicamentos in the upper half of its industry. The industry median Dividend Yield % is 1.93. Dimed Distribuidora de Medicamentos' value of 3.33% is 72.5% above this benchmark. Historically, Dimed Distribuidora de Medicamentos' own Dividend Yield % has ranged from 0.10 to 5.61 over the past decade. While the company's 10-year median is 1.26 vs. the industry median of 1.93, Dimed Distribuidora de Medicamentos has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.93, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dimed Distribuidora de Medicamentos's current Dividend Yield % of 3.33% is 72.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Dimed Distribuidora de Medicamentos and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dimed Distribuidora de Medicamentos's current Dividend Yield % is 3.33%, which is 164% above median its own 10-year median of 1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.64, compared to a current price of R$11.17 — trading 18.1% below its estimated fair value. The current Dividend Yield % is 3.33%, which is 164% above median its 10-year median of 1.26 and 72.5% above the Drug Manufacturers industry median of 1.93. Dimed Distribuidora de Medicamentos' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Dividend Yield % is 3.33% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued.
The current stock price of R$11.17 is trading 18.1% below its estimated GF Value™ of R$13.64.
GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.
Key valuation signals for BSP:PNVL3:
Dividend Yield %: 3.33% (164% above median its 10-year median of 1.26)
GF Value™: R$13.64 vs. price of R$11.17 (18.1% below fair value)
Industry Position: 72.5% above the Drug Manufacturers median (#136 of 516)
No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dimed Distribuidora de Medicamentos Business Description
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
89GF Score
Get the complete analysis for BSP:PNVL3
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PNVL3 has been successfully added to your 
